NDC 16590-207

NDC 16590-207

NDC 16590-207 is a in the category. It is labeled and distributed by .

Proprietary NameNDC 16590-207
Marketing Category/

Packaging

NDC SPL Data Element Entries

NDC 16590-207-62 [16590020762]

SKELAXIN TABLET
Marketing CategoryNDA
Application NumberNDA013217
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2002-08-30
Inactivation Date2019-11-13

NDC 16590-207-71 [16590020771]

SKELAXIN TABLET
Marketing CategoryNDA
Application NumberNDA013217
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2002-08-30
Inactivation Date2019-11-13

NDC 16590-207-20 [16590020720]

SKELAXIN TABLET
Marketing CategoryNDA
Application NumberNDA013217
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2002-08-30
Inactivation Date2019-11-13

NDC 16590-207-90 [16590020790]

SKELAXIN TABLET
Marketing CategoryNDA
Application NumberNDA013217
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2002-08-30
Inactivation Date2019-11-13

NDC 16590-207-60 [16590020760]

SKELAXIN TABLET
Marketing CategoryNDA
Application NumberNDA013217
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2002-08-30
Inactivation Date2019-11-13

NDC 16590-207-56 [16590020756]

SKELAXIN TABLET
Marketing CategoryNDA
Application NumberNDA013217
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2002-08-30
Inactivation Date2019-11-13

NDC 16590-207-30 [16590020730]

SKELAXIN TABLET
Marketing CategoryNDA
Application NumberNDA013217
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2002-08-30
Inactivation Date2019-11-13

NDC 16590-207-40 [16590020740]

SKELAXIN TABLET
Marketing CategoryNDA
Application NumberNDA013217
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2002-08-30
Inactivation Date2019-11-13

NDC 16590-207-72 [16590020772]

SKELAXIN TABLET
Marketing CategoryNDA
Application NumberNDA013217
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2002-08-30
Inactivation Date2019-11-13

Drug Details


© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.